AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Facial Emotion Recognition in Insomnia and Emotional Regulation

RecruitingNAAges 18 Years - 65 YearsAllUniversity Hospital, Angers
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Introduction Chronic insomnia is a prevalent disorder in the general population, affecting up to 20% according to French National Institute of Health and Medical Research, leading to a decline in quality of life and an increased risk of developing certain psychiatric disorders, notably major depressive episodes. Chronic insomnia, particularly when accompanied by reduced sleep duration, has been associated with cognitive impairments documented in the literature, such as reduced concentration, working memory, vigilance, and certain executive functions. While some studies suggest subjective cognitive impairment in insomnia, it remains inconclusive when objectively measured. Individuals with chronic insomnia often report a global deterioration in social life, characterized by irritability, attentional difficulties, asthenia, and social isolation. This raises questions about potential impair

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Pre-inclusion criteria * Age between 18 and 65 * Signed consent to participate in the study * Person affiliated to or benefiting from a social security scheme * For insomnia group: known insomnia (patient treated for insomnia) Inclusion criteria: * Insomnia group: ISI \>14 (between 15 and 28 = clinical insomnia) * Control group: ISI \< 8 (between 0 and 7 = no insomnia) Non-pre-inclusion criteria * Known psychiatric disorders (Characterized depressive episode, Bipolar disorder, Schizophrenia and other delusional disorders, Specified anxiety disorder (social anxiety, generalized anxiety disorder), Obsessive-compulsive disorder (OCD), Eating disorders, Neurodevelopmental disorders (ASD, ADHD), Active addictive disorders (excluding tobacco), ...) * Taking antidepressant, neuroleptic or thymoregulator medication * Taking a benzodiazepine with a long half-life (\>12 hours) * Condition requiring hospitalization in the month preceding the study * Known sequelae or progressive neurological disease * Known significant ophthalmological condition * Pregnancy or breast-feeding * Person deprived of liberty by judicial or administrative decision * Person subject to a legal protection measure * Person under psychiatric care without consent * For control group: no known insomnia Non-inclusion criteria : \- Psychiatric disorders identified during psychiatric interview
๐Ÿ’Š

What it tests

  • Facial emotion recognition test with and without eye-tracking and Cognitive Emotion Regulation. Questionnaire (CERQ)
๐Ÿ“

Where

1 site
CHU Angers
Angers, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy